Showing results (31-40 of 84) with videos related to
Sort By:
Pageof 9
The Australian and New Zealand Journal of Psychiatry|September 20, 2005
Nature of depression in patients with HIV/AIDSFiona Judd, Angela Komiti, Phyllis Chua, et al.Antiviral Therapy|March 15, 2017
CD4:CD8 ratio comparison between cohorts of HIV-positive Asians and Caucasians upon commencement of antiretroviral therapyKathy Petoumenos, Jun Yong Choi, Jennifer Hoy, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2015
Recommendations for evaluation and management of bone disease in HIVTodd T Brown, Jennifer Hoy, Marco Borderi, et al.HIV Clinical Trials|October 9, 2004
Progression of lipodystrophy (LD) with continued thymidine analogue usage: long-term follow-up from a randomized clinical trial (the PIILR study)Allison Martin, Don Smith, Andrew Carr, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 2, 2009
Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: The Asia Pacific HIV Observational Database (APHOD)Sam Egger, Kathy Petoumenos, Adeeba Kamarulzaman, et al.Plos One|June 16, 2011
Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational DatabaseReena Rajasuriar, Maelenn Gouillou, Tim Spelman, et al.Plos One|July 11, 2013
Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific regionStephen Wright, Mark A Boyd, Evy Yunihastuti, et al.Plos One|September 9, 2017
Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years-The Australian Positive & Peers Longevity Evaluation Study (APPLES)Kathy Petoumenos, Robin Huang, Jennifer Hoy, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 28, 2014
Determinants of viremia copy-years in people with HIV/AIDS after initiation of antiretroviral therapyStephen T Wright, Jennifer Hoy, Brian Mulhall, et al.Antiviral Therapy|October 9, 2009
Efficacy and safety of darunavir/ritonavir in treatment-experienced HIV type-1 patients in the POWER 1, 2 and 3 trials at week 96Keikawus Arastéh, Patrick Yeni, Anton Pozniak, et al.Pageof 9